Cargando…

The safety and effectiveness of clopidogrel versus aspirin in Kawasaki disease with mild-to-moderate liver injury

Kawasaki disease can be combined with liver injury. As a mainstay treatment for Kawasaki disease, aspirin may cause liver injury. This study aimed to compare the safety and effectiveness of clopidogrel versus aspirin in Kawasaki disease with mild-to-moderate liver injury. This study retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Lichao, Wang, Wei, Wang, Huafeng, Xu, Zhufei, Zhou, Shulai, Geng, Zhimin, Fu, Songling, Xie, Chunhong, Zhang, Yiying, Wang, Yujia, Gong, Fangqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603134/ https://www.ncbi.nlm.nih.gov/pubmed/37884573 http://dx.doi.org/10.1038/s41598-023-45647-6

Ejemplares similares

Notch4 signaling pathway in a Kawasaki disease mouse model induced by Lactobacillus casei cell wall extract
por: Gao, Lichao, et al.
Publicado: (2017)

Crucial transcripts predict response to initial immunoglobulin treatment in acute Kawasaki disease
por: Geng, Zhimin, et al.
Publicado: (2020)

Altered Monocyte Subsets in Kawasaki Disease Revealed by Single-cell RNA-Sequencing
por: Geng, Zhimin, et al.
Publicado: (2021)

KCa3.1 Inhibition of Macrophages Suppresses Inflammatory Response Leading to Endothelial Damage in a Cell Model of Kawasaki Disease
por: Zheng, Fenglei, et al.
Publicado: (2021)

The role of Ca(2+)/NFAT in Dysfunction and Inflammation of Human Coronary Endothelial Cells induced by Sera from patients with Kawasaki disease
por: Wang, Ying, et al.
Publicado: (2020)

Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease
por: Xie, Tian, et al.
Publicado: (2017)

The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease
por: Sun, Yameng, et al.
Publicado: (2020)

A new model to predict intravenous immunoglobin-resistant Kawasaki disease
por: Hua, Wang, et al.
Publicado: (2017)

The Network of Pro-Inflammatory Factors CD147, DcR3, and IL33 in the Development of Kawasaki Disease
por: Qi, Yanqi, et al.
Publicado: (2021)

Reverse regulation of soluble receptor for advanced glycation end products and proinflammatory factor resistin and S100A12 in Kawasaki disease
por: Qi, Yanqi, et al.
Publicado: (2012)

Receptor for advanced glycation end products involved in circulating endothelial cells release from human coronary endothelial cells induced by C-reactive protein
por: Zhou, Shulai, et al.
Publicado: (2015)

Similarities and differences between MIS-C and KD: a systematic review and meta-analysis
por: Tong, Tong, et al.
Publicado: (2022)

Aspirin and Clopidogrel Resistance
por: Sztriha, Laszlo K., et al.
Publicado: (2004)

Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis
por: Tan, Shuai, et al.
Publicado: (2015)

Cost‐Effectiveness of Clopidogrel‐Aspirin Versus Aspirin Alone for Acute Transient Ischemic Attack and Minor Stroke
por: Pan, Yuesong, et al.
Publicado: (2014)

The Therapeutic Effects of EFNB2-Fc in a Cell Model of Kawasaki Disease
por: Tao, Yijing, et al.
Publicado: (2023)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Qu, Jianyu, et al.
Publicado: (2021)

MTHFR C677T Polymorphism and Risk of Congenital Heart Defects: Evidence from 29 Case-Control and TDT Studies
por: Wang, Wei, et al.
Publicado: (2013)

Comparative effect of clopidogrel and aspirin versus aspirin alone on laboratory parameters: a retrospective, observational, cohort study
por: Takahashi, Yasuo, et al.
Publicado: (2013)

Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
por: Khazaei, Mojtaba, et al.
Publicado: (2019)

The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
por: Kulik, Alexander, et al.
Publicado: (2005)

Aspirin and clopidogrel resistance: methodological challenges and opportunities
por: Gasparyan, Armen Yuri
Publicado: (2010)

Aspirin/clopidogrel: Lack of efficacy: case report
Publicado: (2020)

Clinical features of Streptococcus intermedius infection in children: a case series study
por: Xu, Zhufei, et al.
Publicado: (2023)

Clopidogrel improves aspirin response after off-pump coronary artery bypass surgery
por: Wang, Xuezhong, et al.
Publicado: (2014)

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
por: Neubauer, Horst, et al.
Publicado: (2011)

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
por: Bath, Philip M, et al.
Publicado: (2018)

Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial
por: Wang, Yilong, et al.
Publicado: (2019)

A Combination of Aspirin and Clopidogrel Predict More Favorable Dynamics of Platelet Reactivity versus Clopidogrel Alone in the Acute Phase of Minor Stroke
por: Wiśniewski, Adam, et al.
Publicado: (2021)

Clopidogrel with Aspirin versus Aspirin Alone following Intravenous Thrombolysis in Minor Stroke: A 1-Year Follow-Up Study
por: Cao, Hai-Ming, et al.
Publicado: (2022)

Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
por: Algra, Ale, et al.
Publicado: (2000)

Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
por: Hemlata,, et al.
Publicado: (2013)

Clopidogrel Plus Aspirin in Patients With Different Types of Single Small Subcortical Infarction
por: Wang, Guangyao, et al.
Publicado: (2021)

Efficacy and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease undergoing percutaneous coronary intervention: study protocol for a non-inferiority randomized controlled trial
por: Zhou, Tienan, et al.
Publicado: (2023)

Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study
por: Lee, Meng, et al.
Publicado: (2014)

Effect of different doses of aspirin on the prognosis of Kawasaki disease
por: Wang, Jinxin, et al.
Publicado: (2020)

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
por: Sharma, Rakesh K, et al.
Publicado: (2009)

Aspirin plus clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: angiographic and clinical results of a randomized study
por: Dalmau, Maria J, et al.
Publicado: (2015)

Comparative effect of clopidogrel plus aspirin and aspirin monotherapy on hematological parameters using propensity score matching
por: Hayasaka, Masatoshi, et al.
Publicado: (2013)

Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis
por: Hao, Qiukui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jduifv16u6m1oo64kh330q3d4b